Navigation Links
Combo Therapy Knocks Out Melanoma Tumors
Date:6/1/2008

Chemo was more effective after a protein in growths was inhibited, researchers say

SUNDAY, June 1 (HealthDay News) -- Chemotherapy may be more effective on melanoma tumors if a protein frequently found in the growth can first be disabled, a new study reports.

Researchers at the Duke Comprehensive Cancer Center found the drug ADH-1, which makes it difficult for cells to properly bind to one another, helped chemotherapy completely destroy the tumors in twice as many patients than with chemo alone. Sixteen people with regionally advanced melanoma, in which the cancerous growths appear and spread mainly on the limbs, participated in the pilot study.

"Eight of the patients in the study had complete responses to therapy, meaning their tumors completely disappeared," study lead investigator Dr. Georgia Beasley, a medical student at Duke, said in a prepared statement. "This is very encouraging, and we look forward to continuing this study and then eventually moving on to a phase III trial."

Without ADH-1, patients generally have complete responses about 25 percent to 35 percent of the time.

"When chemotherapy was applied to the tumor in this weakened state, it was much more effective compared to conventional therapy alone," study senior investigator Dr. Douglas Tyler, a surgeon at Duke and the Durham Veterans Affairs Medical Center, said in a prepared statement.

The researchers were expected to present their findings Sunday at the American Society of Clinical Oncology annual meeting, in Chicago.

"These early results really speak to the importance of developing combination therapies," Beasley said. "Earlier animal results showed that using ADH-1 alone was not an effective treatment, but in combination with chemotherapy, the results, both pre-clinically and clinically, have been very exciting."

Malignant melanoma is increasing at a rate faster than any other cancer -- 60,000 new cases are expected to be diagnosed this year in the United States alone. When the growths spread beyond the primary site, the disease is rarely curable, and treatment is limited.

More information

The American Academy of Family Physicians has more about melanoma.



-- Kevin McKeever



SOURCE: Duke University Medical Center, news release, June 1, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Combo Kidney-Pancreas Transplant Boosts Survival in Diabetics
2. Breast cancer risk amplified by additional genes in combo with BRCA mutation
3. Celebrex-Lipitor combo may halt prostate cancer
4. Green Tea, Mushroom Extract Combo Slows Sarcomas
5. Hormone Combo May Provide Reversible Male Birth Control Tool
6. LG Electronics Debuts Unique Allergen-Reducing Steam Washer/Dryer Combo
7. Combo Treatment Ups Survival When Cancer Spreads to Abdominal Lining
8. MRI/PET scanner combo
9. Treatment Combo for Pancreatic Cancer Has Limited Benefit
10. Raised Breast Cancer Risk Persists After Combo HRT Stopped
11. Combo Treatment Best for Melanoma, Advanced Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... East Los ... dental extractions. Currently, patients can visit Dr. Assili to receive any dental extraction treatment ... offer, and it expires June 30, 2016. With the lower price, patients can more ...
(Date:5/2/2016)... ... May 02, 2016 , ... Zitter Health Insights , ... Satisfaction Award that will recognize specialty pharmacies for their achievements in customer satisfaction. ... Specialty Pharmacy Patient Satisfaction Survey compiled throughout 2016. Results will be published in ...
(Date:5/2/2016)... Fla. (PRWEB) , ... May ... ... medical researchers report that many commonly used prescription medications, including anxiolytics, painkillers, ... To mitigate these risks, Novus Medical Detox Center —a leading Florida-based ...
(Date:5/2/2016)... ... May 02, 2016 , ... TeleMedCo™, a new company developing ... and improve the rapid diagnosis, triage and admission of patients leveraging IBM Watson’s ... mobile experience for the first time at GENBAND’s Perspectives16 conference. , TeleMedCo ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... Atlantic Information ... CMS’s Medicare Part B Payment Model Could Transform the Pharma Landscape .” CMS recently ... on reducing its spend on provider-administered drugs while preserving care provided to beneficiaries. The ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
(Date:4/27/2016)... Italy , April 27, 2016 ... linear accelerator (MR-linac) platform will be the focal point ... meeting of the European Society for Radiotherapy & Oncology, ... Elekta,s MR-linac integrates a state-of-the-art radiotherapy system and a ... physician to clearly see the patient,s anatomy in real ...
(Date:4/27/2016)... April 27, 2016 Tie-up with ... initiative to save newborns   Fortis ... & newborns in collaboration with Breast Milk Foundation (BMF), a ... Pasteurized Human Milk Bank, ,Amaara, in Delhi-NCR today. This non-profit ... source for infants and should be available to babies deprived ...
Breaking Medicine Technology: